

Boost For Danish Medical Cannabis Patients Following Canntrust Scandal
FOLLOWING a two-and-half-year break oil products have returned to the Danish medical cannabis access programme in a move which is
FOLLOWING a two-and-half-year break oil products have returned to the Danish medical cannabis access programme in a move which is
UKRAINE is poised permit the use of medical cannabis opening up the potential treatment to over two million people. The
FUELLED by last year’s significant progress the European cannabis industry is looking forward to further positive developments in 2022. While
Leading German Cannabis Lawyer Kai-Friedrich Niermann reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead
Biotech start-up Overseed has been awarded the first licence for agronomic and genetic research on cannabis in France by the
IRELAND now has its first patient through the state-approved Medical Cannabis Access Programme (MCAP) some four years after it was
Akanda Corp has announced that it has closed a private placement for aggregate gross proceeds of $5,316,000. The Company intends
Drug policy specialist Natalie O’Regan on Ireland’s faltering Medical Cannabis Access Programme THE Medical Cannabis Access Programme (MCAP) was launched
IN an industry first, LYPHE is bringing patients to the table to explore how to improve the patient experience across
FOLLOWING its listing on the London Stock Exchange in May this year Oxford Cannabinoid Technologies (OCT) has seen more than
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.